Serum calcium concentration and prostate cancer risk: A multicenter study

Nutrition and Cancer

Volumn 65, Issue 7, 2013, Pages 961-968

  Salem, Sepehr ^a,b   Hosseini, Mostafa ^a   Allameh, Farzad ^a   Babakoohi, Shahab ^c   Mehrsai, Abdolrasoul ^a   Pourmand, Gholamreza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM ION; SEX HORMONE;

AGED; ARTICLE; BODY MASS; CALCIUM BLOOD LEVEL; CANCER PREVENTION; CANCER RISK; CONTROLLED STUDY; DEMOGRAPHY; DRINKING BEHAVIOR; EDUCATION; FAMILY HISTORY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MULTICENTER STUDY; OCCUPATION; PROSPECTIVE STUDY; PROSTATE CANCER; SMOKING HABIT;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CALCIUM; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; GONADAL STEROID HORMONES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RISK FACTORS;

EID: 84888385683     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.806936     Document Type: Article

References (44)

1. Hsing AW and Chokkalingam AP: Prostate cancer epidemiology. Front Biosci 11, 1388-1413, 2006.
2. Pourmand G, Salem S, Mehrsai A, LotfiM, AmirzargarMA, et al.: The risk factors of prostate cancer: a multicentric case-control study in Iran. Asian Pac J Cancer Prev 8, 422-428, 2007.
3. Pourmand G, Salem S, Moradi K, Nikoobakht MR, Tajik P, et al.: Serum selenium level and prostate cancer: a case-control study. Nutr Cancer 60, 171-176, 2008.
4. Crawford ED: Epidemiology of prostate cancer. Urology 62, 3-12, 2003.
5. Sim HG and Cheng CW: Changing demography of prostate cancer in Asia. Eur J Cancer 41, 834-845, 2005.
6. Salem S, Salahi M, Mohseni M, Ahmadi H, Mehrsai A, et al.: Major dietary factors and prostate cancer risk: a prospective multicenter casecontrol study. Nutr Cancer 63, 21-27, 2011.
7. Chan JM, Stampfer MJ,Ma J, Gann PH, Gaziano JM, et al.: Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. Am J Clin Nutr 74, 549-554, 2001.
8. Tseng M, Breslow RA, Graubard BI, and Ziegler RG: Dairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow-up Study cohort. Am J Clin Nutr 81, 1147-1154, 2005.
9. Giovannucci E, Liu Y, Stampfer MJ, and Willett WC: A prospective study of calcium intake and incident and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev 15, 203-210, 2006.
10. Mitrou PN, Albanes D., Weinstein SJ, Pietinen P., Taylor PR, et al.: A prospective study of dietary calcium, dairy products and prostate cancer risk (Finland). Int J Cancer 120, 2466-2473, 2007.
11. Fraser DR: Exploration of possible mechanisms linking vitamin D status and dietary calcium to prostate cancer. Br J Nutr 97, 596-597, 2007.
12. Gao X, LaValley MP, and Tucker KL: Prospective studies of dairy product and calcium intakes and prostate cancer risk: a metaanalysis. J Natl Cancer Inst 97, 1768-1777, 2005.
13. HuncharekM,Muscat J, and Kupelnick B: Dairy products, dietary calcium and vitamin D intake as risk factors for prostate cancer: a meta-analysis of 26,769 cases from 45 observational studies. Nutr Cancer 60, 421-441, 2008.
14. Baron JA, Beach M, Wallace K, Grau MV, Sandler RS, et al.: Risk of prostate cancer in a randomized clinical trial of calcium supplementation. Cancer Epidemiol Biomarkers Prev 14, 586-589, 2005.
15. Skinner HG and Schwartz GG: Serum calcium and incident and fatal prostate cancer in the National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 17, 2302-2305, 2008.
16. Skinner HG and Schwartz GG: A prospective study of total and ionized serum calcium and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev 18, 575-578, 2009.
17. Halthur C, Johansson AL, Almquist M, Malm J, Gr̈onberg H, et al.: Serum calcium and the risk of prostate cancer. Cancer Causes Control 20, 1205-1214, 2009.
18. Baradaran N, Ahmadi H, Salem S, Lotfi M, Jahani Y, et al.: The protective effect of diabetes mellitus against prostate cancer: role of sex hormones. Prostate 69, 1744-1750, 2009.
19. Payne RB, Little AJ, Williams RB, and Milner JR: Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J 4, 643-646, 1973.
20. Rothman KJ, and Greenland S: Modern Epidemiology. Lippincott William and Wilkins, Philadelphia, 1998
21. Ahn J, Albanes D, Peters U, Schatzkin A, and Lim U, et al.: Prostate, Lung, Colorectal, and Ovarian Trial Project Team. Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 16, 2623-2630, 2007.
22. Schwartz GG and Hulka BS: Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res 10, 1307-1311, 1990.
23. Reichel H, Koeffler HP, and Norma AW: The role of the vitamin D endocrine system in health and disease. N Engl J Med 320, 980-991, 1989.
24. Schwartz GG: Is serum calcium a biomarker of fatal prostate cancer? Future Oncol 5, 577-580, 2009.
25. Giovannucci E: Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: a hypothesis. Cancer Causes Control 9, 567-582, 1998.
26. Ahn J, Peters U, Albanes D, Purdue MP, Abnet CC, et al.: Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Project Team. Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst 100, 796-804, 2008.
27. Platz EA, Leitzmann MF, Hollis BW, Willett WC, and Giovannucci E: Plasma 1,25-dihydroxy-and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 15, 255-265, 2004.
28. Travis RC, Crowe FL, Allen NE, Appleby PN, Roddam AW, et al.: Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition (EPIC). Am J Epidemiol 169, 1223-1232, 2009.
29. Chung M, Balk EM, Brendel M, Ip S, Lau J, et al.: Vitamin D and calcium: a systematic review of health outcomes. Evid Rep Technol Assess (Full Rep) 183, 1-420, 2009.
30. Tavani A, Bertuccio P, Bosetti C, Talamini R, Negri E, et al.: Dietary intake of calcium, vitamin D, phosphorus and the risk of prostate cancer. Eur Urol 48, 27-33, 2005.
31. Gilbert R, Martin RM, Beynon R, Harris R, Savovic J, et al.: Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose-response meta-analysis. Cancer Causes Control 22, 319-340, 2011.
32. Ray R, Banks M, Abuzahra H, Eddy VJ, Persons KS, et al.: Effect of dietary vitaminDand calcium on the growth of androgen-insensitive human prostate tumor in a murine model. Anticancer Res 32, 727-731, 2012.
33. Chung M, Lee J, Terasawa T, Lau J, and Trikalinos TA: Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 155, 827-838, 2011.
34. Levi F, Pasche C, Lucchini F, and La Vecchia C: Dietary intake of selected micronutrients and breast-cancer risk. Int J Cancer 91, 260-263, 2001.
35. Qin LQ, Wang PY, Kaneko T, Hoshi K, and Sato A: Estrogen: one of the risk factors in milk for prostate cancer. Med Hypotheses 62, 133-142, 2004.
36. Gunnell D, Oliver SE, Peters TJ, Donovan JL, Persad R, et al.: Are dietprostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men. Br J Cancer 88, 1682-1686, 2003.
37. Skinner HG and Schwartz GG: The relation of serum parathyroid hormone and serum calcium to serum levels of prostate-specific antigen: a populationbased study. Cancer Epidemiol Biomarkers Prev 18, 2869-2873, 2009.
38. Mataix J, Aranda P, Ĺopez-Jurado M, Śanchez C, Planells E, et al.: Factors influencing the intake and plasma levels of calcium, phosphorus and magnesium in southern Spain. Eur J Nutr 45, 349-354, 2006.
39. Almquist M, Manjer J, Bondeson L, and Bondeson AG: Serum calcium and breast cancer risk: results from a prospective cohort study of 7,847 women. Cancer Causes Control 18, 595-602, 2007.
40. Fuszek P, Lakatos P, Tabak A, Papp J, Nagy Z, et al.: Relationship between serum calcium and CA 19-9 levels in colorectal cancer. World J Gastroenterol 10, 1890-1892, 2004.
41. Sprague BL, Skinner HG, Trentham-Dietz A, Lee KE, Klein BE, et al.: Serum calcium and breast cancer risk in a prospective cohort study. Ann Epidemiol 20, 82-85, 2010.
42. Prins GS and Korach KS: The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 73, 233-244, 2008.
43. Ahmadi H, Allameh F, Baradaran N, Montaser-Kouhsari L, Bazargan-Hejazi S, et al.: Circulating sex hormones play no role in the association between sexual activity and the risk of prostate cancer. J SexMed 8, 905-913, 2010.
44. Chu DZ, Hussey MA, Alberts DS, Meyskens FL Jr, Fenoglio-Preiser CM, et al.: Colorectal Chemoprevention Pilot Study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesions. Clin Colorectal Cancer 10, 310-316, 2011.